Breaking AI & Tech News Analyzed

OpenAI, the parent company of ChatGPT, has made a significant move into the media business by acquiring TBPN, a technology-focused talkshow closely watched by Silicon Valley insiders. The show, hosted by John Coogan and Jordi Hays, broadcasts live for three hours every weekday from Los Angeles, featuring guests such as founders, venture capitalists, and major figures in the technology world. The acquisition is part of OpenAI's efforts to engage more authentically with the public at a pivotal moment for artificial intelligence. Fidji Simo, OpenAI's chief of strategy, stated that the company aims to create a space for real, constructive conversation about the changes AI creates. She emphasized that TBPN will continue to run its programming, choose its guests, and make its own editorial decisions, ensuring its credibility is maintained. TBPN is known for its unique ritual where guests announce their latest fundraising haul, accompanied by the hosts banging a gong. The show is broadcast on X, YouTube, and Spotify, and will continue to air daily at its regular time. Coogan expressed his excitement about the acquisition, calling it a 'full circle moment' given his longstanding ties to OpenAI's chief executive, Sam Altman, who funded his first company in 2013. This strategic move comes on the heels of OpenAI closing a $122 billion funding round amid the AI boom, highlighting the company's growing influence and investment in the technology sector.

OpenAI, the company behind the popular AI chatbot ChatGPT, has announced that it has successfully closed a massive $122 billion funding round. This significant investment has propelled the company's valuation to an impressive $852 billion, solidifying its position as one of the most highly valued private companies globally. The funding round, which is one of the largest in Silicon Valley's history, saw participation from tech giants such as Amazon, Nvidia, and SoftBank, which committed $110 billion. A select group of individual investors also contributed approximately $3 billion to the round. This substantial influx of capital comes as OpenAI prepares for a potential initial public offering (IPO) later this year, one of the most anticipated public listings in decades. Despite the positive news, OpenAI faces numerous challenges, including lawsuits, competition from rival AI firms, and public distrust. The company is also dealing with questions over the sustainability of the AI boom and its ability to deliver on its ambitious promises. OpenAI's CEO, Sam Altman, and the company will be involved in a closely watched trial in April, as Elon Musk sues OpenAI, alleging a breach of a founding agreement. In a blog post, OpenAI touted the funding round as a testament to its promising future and the legitimacy of its technology. The company aims to build a 'unified AI superapp', centralizing ChatGPT, coding products, web browsing, and AI agents. OpenAI currently generates $2 billion a month in revenue but faces significant financial challenges, with internal forecasts indicating that it may not become profitable until 2030.

Robert F Kennedy Jr, the US health secretary, has unveiled a chaotic and unpredictable agenda for public health policy under his 'Make America Healthy Again' (Maha) initiative. His approach tends to favor personal choice and autonomy over large-scale, mandatory public health interventions, such as childhood vaccine requirements.The Maha agenda has raised concerns over the potential risks associated with injectable peptide drugs. Mr. Kennedy plans to open up the sale of 'about 14' of these drugs to the public, despite the US Food and Drug Administration (FDA) restricting 17 peptides in 2023 due to 'potential significant safety risks'. None of these peptides have been proven to be safe or effective for human use.The peptides in question are often promoted for biological enhancement, such as increasing muscle mass or cognitive benefits, but the evidence for these effects in humans is thin. Reports of people self-administering peptide therapies, usually bought from China 'for research use only', are widespread, particularly in Silicon Valley.The Maha project wants to make the grey market the only market, effectively sanctioning mass public use of unproven treatments. Peptides are clearly drugs and shouldn’t be allowed for widespread use without rigorous clinical trials. Opening loopholes for sale would undermine the precautionary principle that has successfully led public health policy for generations.It is also worth noting that other governments are unlikely to be as cavalier as Mr. Kennedy about peptides. However, people everywhere will continue to call for more personal choice and more bodily autonomy, and those conversations are important. The case for safety, proof, and regulation must be made to ensure that public health policy prioritizes the well-being of individuals.

Tracy Kidder, an award-winning narrative nonfiction writer, has passed away at the age of 80. Kidder was known for his ability to transform unlikely subjects into bestsellers, captivating readers with his in-depth research and storytelling skills. Throughout his career, Kidder immersed himself in various worlds, producing richly researched books on topics that may not have seemed like light reading. His work included The Soul of a New Machine, which explored the inner workings of a fledgling computer company in Silicon Valley and earned him the Pulitzer Prize and National Book Award in 1981. Kidder's other notable works include Among Schoolchildren, which highlighted the dedication of an inner-city teacher in Holyoke, Massachusetts, and Old Friends, which chronicled the lives of two friends in a nursing home. His book Mountains Beyond Mountains, about a doctor's efforts to bring healthcare to Haiti, introduced his work to a new generation of readers and inspired numerous universities to add it to their reading lists. Kidder's approach to storytelling was rooted in his belief that small things can have a significant impact. He avoided focusing on his personal interests, such as fishing or baseball, to maintain his objectivity and enthusiasm for his subjects. Kidder saw himself as a storyteller, not a 'literary journalist' or 'creative nonfiction' writer, and believed that nonfiction should not be limited by traditional techniques. Born in New York City in 1945, Kidder attended Harvard University and served in Vietnam, where he documented his experiences in My Detachment, a memoir that offered insights into the lives of support troops.

The chasm between Silicon Valley's tech elite and everyday people is growing ever larger, as the industry doubles down on artificial intelligence. Nvidia's CEO Jensen Huang predicts $1tn in sales by 2028, a staggering figure that equates to 3% of the entire US yearly GDP.Meanwhile, 65% of Americans don't use AI in their work at all, according to Pew Research. The survey also shows that Americans are wary of AI and believe both political parties are regulating it poorly. Meta is reallocating huge amounts of its spending to AI, cutting jobs and scaling back metaverse ambitions. The company's Reality Labs division has recorded losses of $80bn since 2020.In a stark illustration of the divide, Mark Zuckerberg is building an AI agent to perform his work as CEO of Meta. The AI industry is splitting away from the lives of everyday people, with exclusive polling conducted for the Guardian finding that twice as many Americans believe their financial security is getting worse than better.In other tech news, Tesla's Cybertruck has been involved in several fiery crashes, resulting in fatalities and lawsuits. The vehicle's unique design and materials have raised safety concerns, with experts alleging that the truck's design led to these worst-case scenarios.